- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Fesoterodine beads- in-capsule
Total 181 results
-
Catalan Society of Family MedicineFondo de Investigacion SanitariaCompletedChronic Obstructive Pulmonary DiseaseSpain
-
National Cancer Institute (NCI)RecruitingHepatocellular Carcinoma | Hepatocellular Cancer | Metastatic Hepatocellular CarcinomaUnited States
-
Second Affiliated Hospital of Guangzhou Medical...RecruitingHepatocellular Carcinoma | Solid Tumor, AdultChina
-
Translational Research in OncologyBayerRecruitingCarcinoma, HepatocellularKorea, Republic of, United States, Taiwan, Spain, Japan, France, Georgia, Belgium, Germany, Turkey, Italy, Hong Kong, Serbia
-
Radboud University Medical CenterErasmus Medical CenterRecruitingMulti-organ Metastatic Colorectal CancerNetherlands, United Kingdom
-
National Institute of Mental Health (NIMH)CompletedObsessive-Compulsive Disorder | Anxiety Disorders | Generalized Anxiety Disorder | Social Phobia | Separation Anxiety
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Splenic Marginal Zone Lymphoma | Recurrent Small Lymphocytic LymphomaUnited States
-
Stockholm South General HospitalKarolinska InstitutetUnknown
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States
-
Chulalongkorn UniversityWashington University School of Medicine; Mahidol University; Ramathibodi Hospital and other collaboratorsCompletedTreatment EfficacyThailand
-
National Cancer Institute (NCI)CompletedHepatocellular Carcinoma | Unresectable Hepatocellular CarcinomaUnited States
-
University of PennsylvaniaPfizerCompletedOveractive Bladder
-
Brigham and Women's HospitalMedical University of SilesiaCompletedUrinary Incontinence | Urgency UrinaryUnited States
-
Swiss Federal Institute of TechnologyCompletedIron-deficiencySwitzerland
-
Swiss Federal Institute of TechnologyCompletedIron-deficiencySwitzerland
-
Swiss Federal Institute of TechnologyUniversity of StellenboschCompleted
-
Swiss Federal Institute of TechnologyCompleted
-
PfizerCompletedUrinary Bladder, NeurogenicFrance, United States, Spain, Korea, Republic of, United Kingdom, Malaysia, Taiwan, Finland, Japan, Lithuania, Italy, Turkey, Estonia, Slovakia, Belgium, Canada, Germany, Greece, India, Philippines, Poland, Russian Federation, South... and more
-
PfizerCompletedUrinary Bladder, NeurogenicJapan
-
Swiss Federal Institute of TechnologyCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedProstate AdenocarcinomaUnited States
-
Astellas Pharma Singapore Pte. Ltd.CompletedOveractive Bladder (OAB)Korea, Republic of, Taiwan
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedUrge Urinary IncontinenceUnited States
-
University of AlbertaPfizerCompletedOveractive Bladder | Mild Cognitive ImpairmentCanada
-
Samsung Medical CenterSamsung Biomedical Research InstituteCompletedOveractive BladderKorea, Republic of
-
Astellas Pharma Singapore Pte. Ltd.CompletedOveractive Bladder (OAB)Korea, Republic of, Australia
-
Sir Mortimer B. Davis - Jewish General HospitalTerminatedUrinary Bladder, Overactive | Parkinson DiseaseCanada
-
University of British ColumbiaPfizer; Vancouver Coastal Health; International Collaboration on Repair DiscoveriesCompletedAutonomic DysreflexiaCanada
-
Stéphane BolducPfizerCompletedOveractive BladderCanada
-
Stéphane BolducPfizerCompleted
-
PfizerCompletedOveractive BladderCosta Rica, United States, Korea, Republic of, Germany, Slovakia, Ukraine, Belgium, Poland, Czechia
-
PfizerCompleted
-
PfizerCompletedUrinary Bladder, OveractiveCanada, United States, Germany, Russian Federation, Czechia, Egypt, Bulgaria, Finland, Hungary, Korea, Republic of, Mexico, Poland, South Africa, Sweden, Ukraine
-
PfizerCompleted
-
PfizerCompletedOveractive Bladder | Urinary IncontinenceSlovakia
-
PfizerCompletedTreatment of Overactive BladderUnited States
-
PfizerCompletedTreatment of Overactive BladderUnited States
-
Saint Thomas HealthPfizerWithdrawnUrinary Incontinence | Bladder DysfunctionUnited States
-
Swiss Federal Institute of TechnologyCompleted
-
Weill Medical College of Cornell UniversityPfizerCompletedBladder Outlet ObstructionUnited States
-
Swiss Federal Institute of TechnologyCompleted
-
Genelex CorporationUniversity of UtahCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme Deficiency | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome... and other conditionsUnited States
-
Mount Sinai Hospital, CanadaThe Physicians' Services Incorporated Foundation; BaycrestTerminated
-
PfizerCompleted
-
PfizerCompletedOveractive BladderDenmark, United States, Canada, Costa Rica, Belgium, Czech Republic, Colombia, Germany, Hungary, Korea, Republic of, Spain, Chile, Taiwan, India, Brazil, Singapore, Greece, Hong Kong, Italy, Sweden, Poland, South Africa, Malaysia, Rom... and more
-
Washington University School of MedicineCompletedOveractive BladderUnited States
-
Swiss Federal Institute of TechnologyCompletedIron Deficiency
-
University of PennsylvaniaPfizerCompletedOveractive BladderUnited States